A synthesis of a rationally designed inhibitor of cytochrome P450 8B1, a therapeutic target to treat obesity.
A synthesis of a rationally designed inhibitor of cytochrome P450 8B1, a therapeutic target to treat obesity.
复制标题
DOI:
10.1016/j.steroids.2021.108952
复制
发表时间:
2022-03
期刊:
影响因子:
2.7
通讯作者:
Yoshimoto FK
中科院分区:
文献类型:
--
作者:
Chung E;Offei SD;Aondo Jia UT;Estevez J;Perez Y;Arman HD;Yoshimoto FK
Mice that lack the gene for expression of cytochrome P450 8B1 (P450 8B1) resist weight gain and improve glucose tolerance when fed a high-fat diet. Thus, the inhibition of P450 8B1 is a target to treat obesity-associated metabolic disorders. P450 8B1 is the enzyme that hydroxylates its substrate, 7α-hydroxy-cholest-4-en-3-one to 7α-,12α-dihydroxycholest-4-en-3-one, which ultimately results in the formation of cholic acid. Cholic acid is the 12α-hydroxylated bile acid implicated in enhanced absorption of cholesterol. The synthesis of a rationally designed inhibitor for P450 8B1 was achieved through the incorporation of a C12-pyridine in the C-ring of a steroid molecule. Seven days of new inhibitor treatment showed attenuation of glucose intolerance in mice that were fed a high fat and a high sucrose diet (HFHS) without affecting body weight. Taken together, these promising results will lead to a P450 8B1 inhibitor as a potential therapeutic strategy to treat obesity-associated insulin resistance.
登录
查看更多内容
影响因子:
5.7
作者:
Toren, Paul J.;Kim, Soojin;Gleave, Martin E.
通讯作者:
Gleave, Martin E.
影响因子:
2.6
作者:
Sellers, RS;Antman, M;Furst, SM
通讯作者:
Furst, SM
影响因子:
4.9
作者:
Choi, J-Y;McGregor, R. A.;Choi, M-S
通讯作者:
Choi, M-S
影响因子:
5.7
作者:
Liu C;Armstrong CM;Lou W;Lombard A;Evans CP;Gao AC
通讯作者:
Gao AC
影响因子:
3.3
作者:
Axling U;Cavalera M;Degerman E;Gåfvels M;Eggertsen G;Holm C
通讯作者:
Holm C